Building scalable viral vector manufacturing models

As viral vectors become central to advanced therapy development, manufacturing systems must evolve to meet clinical and commercial demands. This discussion highlights practical approaches for building scalable, reproducible production platforms while addressing process complexity and regulatory expectations. 

Key takeaways 

• Outline principles for scalable viral vector manufacturing 

• Examine strategies to maintain product quality and potency at scale 

• Discuss modular and flexible process designs to enhance throughput 

• Evaluate process monitoring, control, and digital integration for consistency 

• Review approaches to align manufacturing scale with regulatory compliance